Meet the Experts

Donald R. Johnston is senior director of BioWorld and BioWorld MedTech. Don has been at the helm of BioWorld, BioWorld MedTech and their related family of biopharmaceutical and med-tech news and data products. Don graduated from the University of California, Berkeley and also has a master’s degree in journalism from Columbia University in New York. He was a newspaper reporter and editor in both consumer and trade magazine publishing before entering the newsletter business. He is a frequent speaker at both industry and publishing events, and is proud to have been at every Biotechnology Industry Organization (BIO) meeting since Toronto in 1994.

Lynn Yoffee is the executive editor of BioWorld. She leads a team of journalists from around the world who produce daily insider intelligence on key business, scientific and regulatory news related to the biopharmaceutical industry. Lynn managed the BioWorld group in the mid 1990s and rejoined the team in 2010. A senior-level editor with 20+ years of diversified experience in health care and medical science publishing for targeted B2B and consumer audiences, Lynn has managed, conceived and launched more than two dozen specialty publications on health and medical topics ranging from nanotechnology to plastic surgery.

Jennifer Boggs joined the BioWorld group in 2004 as a staff writer after working for a number of years in newspapers. She was promoted to the position of assistant managing editor in 2008 and in 2011 was appointed as BioWorld’s managing editor. Jennifer was part of a BioWorld team that in 2009 produced a series examining how the recession impacted key biotechnology arenas which garnered a Specialized Information Publishers Association award. More recently, she won another SIPA award for her work covering Sanofi-Aventis SA’s efforts to acquire Genzyme Corp., one of the biggest acquisition deals in the history of the biotech industry.

Peter Winter, editor of BioWorld Insight, is a seasoned science journalist and editor based in Winnipeg, Canada. He was the founder and editor of Canadian Biotech News, a weekly newsletter that served the industry for 20 years. In 2005 he joined Burrill & Co., of San Francisco, as editor of the Burrill Biotech Annual Report series, a publication that tracks the financial and business progress of the global biotechnology industry. He returned to Canada in 2011. Peter is the recipient of the Science Journalism Laureate Award from Purdue University (2009). Educated in biochemistry and psychology, he received his undergraduate degree from the University of London.

Anette Breindl, PhD has been BioWorld’s science editor since 2004. Prior to joining BioWorld, she planned and executed corporate communications strategies for biotechnology companies at Akins + Associates, a public relations firm focused exclusively on life sciences clients. She has also worked as a freelance writer for U.S. and German publications, and co-authored several peer-reviewed papers. Anette earned a PhD from the Leibniz Institute for Neurobiology in Magdeburg, Germany, and a BA from the University of California at Berkeley. She has been a recipient of research scholarships from the National Science Foundation and its German equivalent, the Deutsche Forschungsgemeinschaft. Anette is a member of the National Association of Science Writers.

As the Washington editor for BioWorld, Mari Serebrov covers key business and regulatory news related to the biopharmaceutical industry. Mari is a senior-level writer with 25+ years of diversified experience in publishing for academic, business-to-business and consumer audiences. She joined the BioWorld team in 2011.

Randy Osborne has been a writer and editor in biotech for 15 years, mostly at BioWorld, with several years at The Pink Sheet and Deloitte. He also has contributed to Nature Biotechnology and His journalism career, spanning more than 35 years, includes general interest, feature, investigative and technical writing for daily, weekly and monthly newspapers and magazines, as well as radio news. His work has appeared in Newsweek, the Chicago Tribune, Atlanta Journal-Constitution, St. Louis Post-Dispatch, San Francisco Bay Guardian, The Progressive magazine, among others. During off hours, he is director of the nonprofit Carapace, a free monthly event of true personal stories told by ordinary people in Atlanta, which began in 2010 as an offshoot of The Moth in New York, and became independent a year later.

Marie Powers served as a contributing writer for BioWorld before joining the staff in 2011. With more than 20 years on the health care beat, Marie has contributed to a variety of industry publications, including ENT Today, Managed Care Contracting & Reimbursement Advisor, Orthopaedic Practice Management, Neurology Practice Management, Capitation Management Report, Capitation Rates & Data, Physician Profiling & Behavior Change Report, and Women’s Health Center Management. She’s also served as a Contributing Editor to Technology Transfer Tactics.

Michael Fitzhugh joined the BioWorld team as a staff writer in 2014. He has contributed to and edited several in-depth annual reports about health care’s ever changing landscape as an editor in Burrill & Co.’s San Francisco-based media group while reporting about biopharma’s unfolding story. Prior to that, he covered biotechnology and high tech companies for American City Business Journals. He received his MJ from the University of California at Berkeley’s Graduate School of Journalism and holds a BA from the University of Michigan. When unplugged from reporting, he enjoys spending time with his young children and playing fiddle in Berkeley, Calif.

Nuala Moran has been part of the BioWorld team since 1996, covering the scientific and commercial development of the sector in Europe. She is a former managing editor of Nature and was Innovation Editor of the UK national newspaper, The Independent on Sunday. In 2006 Nuala was named as a Science Journalism Laureate by Purdue University.

Based in Dublin, Ireland, Cormac Sheridan has been writing about all aspects of the European and global biotechnology industry for the past 15 years, during which time he has been a correspondent for BioWorld and a regular contributor to many other international and national publications. He has also been a guest lecturer on the BSc in genetics program at University College Cork (UCC) for the last eight years. He has a BSc in microbiology from UCC and an MA in journalism from Dublin City University.

Ann C. Duncan has been senior production editor for BioWorld since 2005. Prior to joining BioWorld, she spent nine years at AHC Media in Atlanta as production editor on several monthly healthcare publications. Ann worked for many years as an administrative assistant and office manager for various companies, including the YMCA, but made a midlife career change and returned to college to earn her BS in communication. She and her daughter both graduated from Kennesaw State University at about the same time. Ann has continued her studies with graduate courses in communication at Georgia State University.

Amanda Lanier joined the BioWorld team in 2004 as the editor of BioScan: The Worldwide Biotech Industry Reporting Service. In addition to managing BioScan, she also serves as the production editor for BioWorld Insight and various market reports, manages the BioWorld Perspectives and MDD Perspectives e-zines, and does writing and graphics creation for BioWorld’s market reports. She has won numerous awards from the Specialized Information Publishers Foundation. Prior to joining BioWorld, she worked as a features writer.

Karen Pihl-Carey is database editor for the financial analysis publication BioWorld Insight and the web-based publication BioWorld Snapshots. She also writes for BioWorld and was part of the team that won a first place award for best reference publication or directory from the Specialized Information Publishers Foundation for BioWorld’s 2010 State of the Industry Report. Prior to joining BioWorld in 1999 as a staff writer, she was a daily newspaper journalist.